{"text": ["How", "AbbVie", "Plans", "To", "Take", "On", "Pfizer,", "Lilly", "\u2014", "And", "Kick", "Its", "Humira", "Habit"], "created_at": "2019-08-16 20:25:16"}
{"text": ["How", "Merck", "Could", "Ride", "'The", "Keytruda", "Wave'", "To", "Dominate", "These", "Rivals"], "created_at": "2019-08-16 20:20:38"}
{"text": ["FDA", "approves", "AbbVie's", "Rinvoq", "to", "treat", "moderate-to-severe", "RA"], "created_at": "2019-08-16 18:06:00"}
{"text": ["UPDATE", "2-AbbVie", "prices", "new", "rheumatoid", "arthritis", "drug", "at", "$59,000/yr"], "created_at": "2019-08-16 16:49:27"}
{"text": ["AbbVie", "Receives", "FDA", "Approval", "of", "RINVOQ\u2122", "(upadacitinib),", "an", "Oral", "JAK", "Inhibitor", "For", "The", "Treatment", "of", "Moderate", "to", "Severe", "Rheumatoid", "Arthritis"], "created_at": "2019-08-16 16:43:00"}
{"text": ["Gilead's", "(GILD)", "Filgotinib", "MAA", "for", "RA", "Accepted", "in", "Europe"], "created_at": "2019-08-16 15:18:54"}
{"text": ["Gilead's", "(GILD)", "Filgotinib", "MAA", "for", "RA", "Accepted", "in", "Europe"], "created_at": "2019-08-16 15:18:54"}
{"text": ["Gilead's", "(GILD)", "Filgotinib", "MAA", "for", "RA", "Accepted", "in", "Europe"], "created_at": "2019-08-16 13:19:01"}
